Skip to content
DraconiticResearch
Search Sources API
203,948 studies31 sourcesUpdated 31 min ago

Immunology

3,062 studies361 in 7 days1,580 in 30 days

Filters
Type
Date
Clear

Latest

3,062 studies

  1. An integrative analysis of transcriptome and single-cell RNA sequencing data identifies cytoskeleton-related prognostic genes in esophageal squamous cell carcinoma
    Shungeng Zhang, Mingyao Song, Bocheng Wei +3
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0ImmunologyCrossref
  2. CD226 overexpression restrains NK92-associated IL-22 and limits an IL-22RA1-pSTAT3-CD155 circuit in the NSCLC tumor microenvironment
    Ziye Hui, Zichan Guo, Yingjun Peng +7
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0ImmunologyCrossref
  3. Regulation of endogenous dsRNA: strategies for self-tolerance
    Jacki Heraud-Farlow, Yu-Pei Chan, Sophia Davidson +1
    Open BiologyPeer-reviewedCC BY 4.0Full textGenetics & genomicsImmunologyCrossrefEurope PMCPMC
  4. Dendritic cell fate plasticity: a central switch in the tumor immune landscape
    Jianing Lu, Yan Zhuang, Dongwei Yao +2
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0ImmunologyFrontiersCrossref
  5. Engineering innate immunity: CRISPR-Cas9 MPO knockout in hematopoietic stem cells abolishes chlorination and PMA-induced NET formation while preserving non-oxidative effector functions
    Szilvia Baron, Aurélien B. L. Colamartino, Jenny Shapiro +6
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0ImmunologyFrontiersCrossref
  6. Preclinical mouse models of multiple myeloma: a clinically oriented guide to model selection, validation, and translational application
    Chunxiu Shen, Yuqin Liu, Jiaowen Deng +4
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0ImmunologyFrontiersCrossref
  7. Identification and monitoring of immune-related adverse reactions of PD-1/PD-L1 inhibitors based on symptom network analysis
    Yuxuan Gao, Yumeng Wang, Lili Yu
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0ImmunologyFrontiersCrossref
  8. Risk stratification for immune-related pneumonitis in esophageal cancer: differential roles of systemic inflammation across severity grades and additive effect of radiation
    Shuai Qie, Yasong Shi, Wenfan Sun +1
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0ImmunologyFrontiersCrossref
  9. Disease-specific C-reactive protein heterogeneity across common infections is associated with a shared systemic inflammatory laboratory profile
    Honghao Guo, Xiaomei Zeng, Xin Wang +1
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0ImmunologyFrontiersCrossref
  10. Neoadjuvant treatment is associated with fibrotic and transcriptional remodeling of tumor-draining lymph nodes in rectal cancer
    Yihang Shi, Zhixun Zhao, Yuegang Li +9
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textImmunologyFrontiersDOAJCrossref
  11. Antigen availability as a determinant of GPC3-directed CAR-T therapy in hepatocellular carcinoma
    Xulin Guo, Ping Sun, Wen Yu +1
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0ImmunologyFrontiersCrossref
  12. AI-driven Immuno-Radio-Multi-Omics in triple-negative breast cancer: mapping the immune landscape for precision immunotherapy
    Ihsane Haloum, Abdallah Badou
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0ImmunologyFrontiersCrossref
  13. Rewiring the breast cancer immune microenvironment through non-coding RNA-macrophage crosstalk: therapeutic vulnerabilities for immune reprogramming
    Sandeep Kumar, Praveen Sharma, Ram Kumar Nema +4
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0ImmunologyFrontiersCrossref
  14. ULBP2 in cancer: ligand state, immune regulation, and therapeutic targeting
    Jiarun Liu, Xiaohuan Wang, Junlin Chen +3
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0ImmunologyFrontiersCrossref
  15. Combined CD8 and granzyme B PET/CT reveals divergent immune responses to radiotherapy plus PD-1 blockade
    Zhihui Hong, Shushan Ge, Yirong Zhu +6
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0ImmunologyFrontiersCrossref
  16. Targeting pyroptosis: therapeutic potential in the immune-inflammatory imbalance of chronic kidney disease
    Yanfang Luo, Xueqin Wu, Wenwei Liu +3
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0ImmunologyFrontiersCrossref
  17. Cancer-associated fibroblasts and extracellular matrix remodeling driving drug resistance and immune evasion in bladder cancer: research progress
    Pengcheng Lu, Liang Zhou
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0ImmunologyFrontiersCrossref
  18. Development of RSV subgroup neutralizing immunity across consecutive seasons with alternating RSV-A and RSV-B predominance
    David N. Springer, Monika Redlberger-Fritz, Christian Borsodi +4
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0ImmunologyFrontiersCrossref
  19. Transient increases in inflammatory cytokines and chemokines are predictive of subsequent HIV-1 infection
    Jake William Rhodes, Shabir Lakhi, Etienne Karita +6
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0ImmunologyFrontiersCrossref
  20. Application of endovascular stent graft in ABO-incompatible living donor kidney transplantation: a case report
    Liping Guo, Yeqi Nian, Qing Du +5
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0ImmunologyFrontiersCrossref
  21. Extracellular galectin-3 preferentially through CD44 and PD-1 binds activated T cells and marks memory-phenotype T cell subsets
    Amal Abouda, Emmanuel T. Alimo, Ako Azimi +4
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0ImmunologyFrontiersCrossref
  22. Molecular and functional evolution of IL-1 superfamily genes in cetacean species
    Isaac Adeyemi Babarinde, Sara Platto, Aldo Tagliabue +2
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0ImmunologyFrontiersCrossref
  23. Hemodialysis patients exhibit T-cell activation accompanied by an enhanced frequency of IFN-γ+CD4+/CD8+ T cells
    Xuya Chen, Danxia Jin, Haoyang Guo +3
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0ImmunologyFrontiersCrossref
  24. A bivalent oral vaccine against Micropterus salmoides rhabdovirus and largemouth bass ranavirus based on yeast surface display technology
    Boge Gu, Pengzhen Yu, Hongyang Xu +3
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0ImmunologyFrontiersCrossref
  25. Serum sCD163: a novel predictor of early neurological deterioration in non-reperfused acute ischemic stroke
    Meijuan Yan, Lihui Shao, Jun Lu
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0ImmunologyFrontiersCrossref